Lobbying disclosures · Lobbying report
INCY: third_quarter 2026 lobbying report
Issues relating to CMS coverage and reimbursement policies.
Follow INCY- Became public
- Oct 18, 2026, 8:08 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 11, 2026, 6:38 AM EST
Why this is connected
Legal-name match: INCYTE CORPORATION is INCYTE CORP (https://www.sec.gov/Archives/edgar/data/879169/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $110,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/811befe2-f499-40ef-b246-5a0ed9534596/","filing_uuid":"811befe2-f499-40ef-b246-5a0ed9534596","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/811befe2-f499-40ef-b246-5a0ed9534596/print/","filing_document_content_type":"text/html","income":"110000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kendall Conger","dt_posted":"2026-10-18T20:08:35-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"121 Reynolda Village Way Ste. A","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Winston Salem","registrant_state":"NC","registrant_zip":"27106","registrant":{"id":401109039,"url":"https://lda.gov/api/v1/registrants/401109039/","house_registrant_id":56739,"name":"CHECKMATE GOVERNMENT RELATIONS","description":null,"address_1":"121 Reynolda Village Way Ste. A","address_2":null,"address_3":null,"address_4":null,"city":"Winston Salem","state":"NC","state_display":"North Carolina","zip":"27106","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KENDALL CONGER","contact_telephone":"+1 919-740-1863","dt_updated":"2026-10-13T06:24:23.250297-04:00"},"client":{"id":70274,"url":"https://lda.gov/api/v1/clients/70274/","client_id":70274,"name":"INCYTE CORPORATION","general_description":"Biopharmaceutical Company","client_government_entity":null,"client_self_select":false,"state":"DE","state_display":"Delaware","country":"US","country_display":"United States of America","ppb_state":"DE","ppb_state_display":"Delaware","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-11-11"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues relating to CMS coverage and reimbursement policies.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148771,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"MCDOWELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149198,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"KOURY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153373,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":"LUCAS","last_name":"BLANCHAT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149175,"prefix":null,"prefix_display":null,"first_name":"CHRISTOPHER","nickname":null,"middle_name":null,"last_name":"LACIVITA","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in INCY
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- May 31, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded May 15, 2025 · disclosed May 31, 2025
- Nov 8, 2023$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 10, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Dec 8, 2018$1K–$15K
Sen. Shelley Moore Capito (R-WV)
$1K–$15K · Traded Nov 12, 2018 · disclosed Dec 8, 2018 · Spouse
- Oct 6, 2017$1K–$15K
Sen. Shelley Moore Capito (R-WV)
$1K–$15K · Traded Sep 8, 2017 · disclosed Oct 6, 2017 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.